Although most studies considered abnormal expression of CDK1 as risk factors for a variety of tumors, such as hepatocellular, breast and colorectal [37, 38], several researches had found that CDK1 participated in molecular mechanism of PAH, mainly influencing mitochondrial dynamics [39]. Here, CDK1 is linked to pulmonary arterial hypertension.